Ko G - Search Results

1

Dopamine in schizophrenia: a review and reconceptualization.

Davis KL, Kahn RS, Ko G, Davidson M. Davis KL, et al. Among authors: ko g. Am J Psychiatry. 1991 Nov;148(11):1474-86. doi: 10.1176/ajp.148.11.1474. Am J Psychiatry. 1991. PMID: 1681750 Review.

2

Elevated PLA2 activity in schizophrenics and other psychiatric patients.

Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, Wolkin A, Duncan E, Rotrosen J. Noponen M, et al. Among authors: ko g. Biol Psychiatry. 1993 Nov 1;34(9):641-9. doi: 10.1016/0006-3223(93)90157-9. Biol Psychiatry. 1993. PMID: 8292693

3

Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.

Ko GN, Korpi ER, Kirch DG. Ko GN, et al. J Clin Psychopharmacol. 1989 Jun;9(3):186-90. J Clin Psychopharmacol. 1989. PMID: 2661607 Clinical Trial.

4

Clinical and sensorimotor gating effects of ketamine in normals.

Duncan EJ, Madonick SH, Parwani A, Angrist B, Rajan R, Chakravorty S, Efferen TR, Szilagyi S, Stephanides M, Chappell PB, Gonzenbach S, Ko GN, Rotrosen JP. Duncan EJ, et al. Among authors: ko gn. Neuropsychopharmacology. 2001 Jul;25(1):72-83. doi: 10.1016/S0893-133X(00)00240-2. Neuropsychopharmacology. 2001. PMID: 11377920 Clinical Trial.

5

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN. Goff DC, et al. Among authors: ko gn. J Clin Psychopharmacol. 1998 Aug;18(4):296-304. doi: 10.1097/00004714-199808000-00009. J Clin Psychopharmacol. 1998. PMID: 9690695 Clinical Trial.

6

Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol.

Korpi ER, Ko GN, Phelps BH, Wyatt RJ. Korpi ER, et al. Among authors: ko gn. J Clin Psychopharmacol. 1984 Dec;4(6):332-5. J Clin Psychopharmacol. 1984. PMID: 6512001

7

On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.

Ko GN, Korpi ER, Linnoila M. Ko GN, et al. J Clin Psychopharmacol. 1985 Oct;5(5):253-62. doi: 10.1097/00004714-198510000-00002. J Clin Psychopharmacol. 1985. PMID: 2864357 Review.

8

A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury.

Merchant RE, Bullock MR, Carmack CA, Shah AK, Wilner KD, Ko G, Williams SA. Merchant RE, et al. Among authors: ko g. Ann N Y Acad Sci. 1999;890:42-50. doi: 10.1111/j.1749-6632.1999.tb07979.x. Ann N Y Acad Sci. 1999. PMID: 10668412 Clinical Trial.

9

An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage.

Bullock MR, Merchant RE, Carmack CA, Doppenberg E, Shah AK, Wilner KD, Ko G, Williams SA. Bullock MR, et al. Among authors: ko g. Ann N Y Acad Sci. 1999;890:51-8. doi: 10.1111/j.1749-6632.1999.tb07980.x. Ann N Y Acad Sci. 1999. PMID: 10668413 Clinical Trial.

10

Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.

Hage A, Voisine P, Erthal F, Larose É, Glineur D, Chow B, Tremblay H, Fortier J, Ko G, Une D, Farkouh M, Mesana TG, LeMay M, Kulik A, Ruel M. Hage A, et al. Among authors: ko g. J Thorac Cardiovasc Surg. 2018 Jan;155(1):212-222.e2. doi: 10.1016/j.jtcvs.2017.06.039. Epub 2017 Jun 24. J Thorac Cardiovasc Surg. 2018. PMID: 28734623 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results